Navigation Links
Novo Nordisk To Award $80,000 To Local Programs That Help People Living With Diabetes In Detroit As Part Of Educational Initiative
Date:6/26/2012

DETROIT, June 26, 2012 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, announced today that it is now accepting applications for Novo Nordisk Community Care Detroit, a community-based initiative that supports local programs that educate people living with type 2 diabetes.  The sponsorships are part of the Novo Nordisk Community Care program, which aims to promote sustainable change by working with locally based nonprofit groups in cities across the country to help communities most affected address the growing diabetes crisis.  Novo Nordisk will invest $80,000 as part of the initiative to support organizations in Detroit.  For more information and to download an application form, interested organizations should visit www.NovoNordisk-US.com/CommunityCare

"More than 1.1 million Michigan residents were faced with diabetes in 2010," said Lori Moore, Executive Director of Communications and Public Affairs at Novo Nordisk.  "As an industry leader, Novo Nordisk is committed to reversing the trend of the diabetes crisis.  We recognize that community-based organizations play a critical role in providing diabetes education and care that can help defeat this disease."

In 2011, Novo Nordisk Community Care sponsored more than 20 diverse community-based programs and awarded $415,000 to organizations in Atlanta, Minneapolis, Boston, and Philadelphia.  Last year's sponsored programs were selected for their unique content focused on education and resources for patients, ranging from interactive workshops, material for underserved and minority populations, and faith-based community initiatives.  This year, Novo Nordisk will offer new sponsorship opportunities to eligible nonprofit organizations dedicated to educating and empowering patients in Detroit to become more engaged in their health and management of type 2 diabetes. 

Diabetes has become a global health crisis, and is taking a major toll on our communities, with Detroit bearing a large part of the burden.  A recent model from the Institute for Alternative Futures (IAF), commissioned by Novo Nordisk, estimates that the number of Americans living with diabetes will increase 64% between 2010 and 2025, affecting more than 53 million people.  And, in Michigan, it's estimated that the number of people with diabetes will increase 42% between 2010 and 2025, affecting more than 1.6 million people, including 703,000 people in Detroit.  This dramatic increase could mean a total of $15.8 billion in total medical and indirect societal costs of diabetes for the state of Michigan in 2025.  

If not properly managed, diabetes can lead to other serious health issues such as heart disease, stroke, kidney disease, blindness, amputation, and other complications.

About Novo Nordisk

Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 32,700 employees in 75 countries, and markets its products in more than 190 countries. Novo Nordisk's B shares are listed on NASDAQ OMX Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit novonordisk.com.


'/>"/>
SOURCE Novo Nordisk
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Frost & Sullivan Presents 2012 Clinical Diagnostics Company of the Year Award to GenPath Diagnostics of BioReference Laboratories, Inc.
2. invivodata President Selected as Finalist for Ernst & Young Entrepreneur of the Year Award
3. picoSpin-45 Benchtop NMR Spectrometer a Finalist in the European Life Sciences Awards
4. San Diego Medical Director Wins Two Book Awards For Latest Medical Thriller
5. Exotic Automation & Supply Receives Ford’s 2011 World Excellence Award
6. DOE-CEA Partnership Awards Mentoring Services to Finalists in National Clean Energy Business Plan Competition
7. 2012 American Business Awards?Honors SynCardia with Two Gold Stevie® Awards
8. Delpor Awarded $340K NIH Grant for 3-month Long Acting Risperidone Product in order to Improve Medication Adherence in Schizophrenia and Bipolar Disorder
9. The Scientist Magazine’s 2012 Multimedia Awards—Call for Entries
10. Dr. Victor Ambros and Dr. Gary Ruvkun Win 2012 Dr. Paul Janssen Award for Biomedical Research for Discovery of MicroRNAs
11. 2011-2012 Michael E. DeBakey Journalism Award Winners Announced
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Dec. 8, 2016  Renova™ Therapeutics, a biotechnology ... failure and type 2 diabetes, announced that it ... adeno-associated virus (AAV) vector developed in the laboratory ... at Stanford University. The company plans to use ... therapy product pipeline. "Early research ...
(Date:12/8/2016)... Oxford Gene Technology (OGT), ... panel range with the launch of the SureSeq myPanel™ NGS ... variants in familial hypercholesterolemia (FH). The panel delivers single nucleotide ... single small panel and allows customisation by ,mix and match, ... for LDLR , P C SK9 ...
(Date:12/8/2016)... ... December 08, 2016 , ... This CAST literature review and report looks at ... focus on the economic effects in countries that are major global commodity exporters and ... the resultant risk of low level presence (LLP) puts large volumes of trade worth ...
(Date:12/8/2016)... 8, 2016 Eutilex Co. Ltd. today announced ... $18.9M) Series A financing. This financing round included participation ... and SNU Bio Angel. This new funding brings the ... (US $27.7M) since its founding in 2015. ... development and commercialization of its immuno-oncology programs, expand its ...
Breaking Biology Technology:
(Date:12/5/2016)... , Dec. 5, 2016  The Office ... today published "Can CT Scans Enhance or Replace ... the potential of supporting or replacing forensic autopsies ... CT scan. In response to recommendations ... is exploring using CT scans as a potential ...
(Date:12/2/2016)... , Dec. 1, 2016   SoftServe , ... BioLock , an electrocardiogram (ECG) biosensor analysis ... a key IoT asset. The smart system ensures ... vehicle,s steering wheel and mobile devices to easily ... As vehicle technology advances, so too ...
(Date:11/30/2016)... , Nov. 30, 2016  higi SH ... new partnership initiative targeting national brands, industry thought-leaders ... reward their respective audiences for taking steps to ... its inception in 2012, higi has built the ... impacting over 38 million people who have conducted ...
Breaking Biology News(10 mins):